The structural basis for imatinib resistance in chronic myeloid leukaemia (CML) involves the emergence of imatinib-resistant BCR-ABL point mutations; mutations are usually those that impair drug ...

The Kavli Foundation Lecture Series (supported by The Kavli Foundation) recognizes groundbreaking discoveries by scientists tackling many of the world’s mounting challenges. The American Chemical ...